Diamonds and Dogs
10/22/14Regulus Therapeutics Inc. (RGLS)
Regulus Therapeutics hit the daily double today, up 103.10% to $13.75. The biopharmaceutical company saw its shares soar after positive results from their hepatitis C drug. A single injection of a microRNA therapeutic directed at a genetic target in the liver of hepatitis C patients produced a significant drop in viral load. The drug seems to need to continue to prove itself as it needs to show an RVR off upwards of 80% to compete with current pills from Gilead Sciences. Shares of Regulus climbed nearly $7.00 to a new 52-week high of $15.38 intraday.
Willbros Group Inc. (WG)
Willbros Group is slumping today, down 35.95% to $4.90. The energy infrastructure contractor saw its shares tank after announcing its second quarter earnings results are not reliable as the found significant deterioration in a major pipeline construction project. The deterioration totals approximately $22 to $24 million and consists of the reversal of approximately $8 million in pre-tax income previously recognized by the company, as well as the recognition of an estimated $14 million to $16 million in estimated pre-tax losses at the project's completion. Shares of Willbros hit a new 52-week low of $4.82 intraday.